口服糖皮质激素剂量模式与系统性红斑狼疮器官损伤:全国队列研究
该研究基于瑞典全国登记资料,纳入2006—2022年新诊断系统性红斑狼疮(SLE)患者3,749例(女性82.1%,中位年龄48.0岁),随访至2024年1月,采用加权累积暴露模型分析口服糖皮质激素(GC)剂量模式与器官损伤的关系。结果显示,总体首次器官损伤风险可由过去两年的GC暴露较好捕捉(5 mg/日时校正HR 1.42,95%CI 1.31-1.53),心血管损伤则需追溯过去三年。
要点
- 评估SLE总体器官损伤时,GC暴露时间窗至少应涵盖过去一年。
- 5 mg/日GC暴露下,过去两年窗口与首次器官损伤的校正HR为1.42(95%CI 1.31-1.53)。
- 评估心血管损伤时,GC暴露与疾病活动的时间窗应延长至过去三年。
核心结论
- SLE总体器官损伤风险可由至少过去一年的GC暴露捕捉,心血管损伤则需延长至过去三年。
研究设计与样本
- 基于瑞典全国登记资料联动的新诊断SLE全国队列,2006—2022年诊断,随访至2024年1月,共3,749例,采用加权累积暴露模型并校正混杂因素。
主要发现
- 5 mg/日GC暴露下,过去两年窗口与首次总体器官损伤的校正HR为1.42(95%CI 1.31-1.53),过去一年窗口为1.34(95%CI 1.23-1.42)。
- 心血管损伤风险与过去三年GC剂量模式 substantially 相关。
关键数值与推荐
- 总体器官损伤:过去两年GC暴露(5 mg/日)校正HR 1.42,95%CI 1.31-1.53;过去一年校正HR 1.34,95%CI 1.23-1.42。
- 心血管损伤:过去三年剂量模式对风险增加贡献显著。
临床怎么用
- 临床评估SLE器官损伤风险时,应回顾至少过去一年的口服GC累积暴露。
- 对心血管风险,应追溯过去三年的GC暴露及疾病活动情况。
局限性
- 原文摘要未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Evaluating the relationship between glucocorticoid (GC) exposure and organ damage in systemic lupus erythematosus (SLE) is challenging because GC dose varies over time. It is unclear which exposure time window captures the full impact of GC usage. METHODS: We studied a nationwide cohort of individuals with newly diagnosed SLE from 2006-2022, with follow-up until January 2024, through a linkage of Swedish national registers. Long-term oral GC exposure was assessed from pharmacy dispensations to identify which dosing patterns had the strongest association with organ damage overall, and within the ocular, cardiovascular, peripheral vascular, gastrointestinal, diabetes, and malignancy domains. We used weighted cumulative exposure models to estimate the weights of the average daily dose at different time points and determine the relative importance of exposure on organ damage accrual, adjusted for confounders. RESULTS: Among 3,749 patients with newly diagnosed SLE (82.1% female, median age 48.0 years), the increased risk of first organ damage overall associated with GC dosing was well captured by the past two years (adjusted hazard ratio [HR] 1.42, 95% confidence interval [CI] 1.31-1.53, for 5 mg/day), and fairly well captured by the past one year (adjusted HR 1.34, 95% CI 1.23-1.42, for 5 mg/day). For cardiovascular damage, dose patterns over the past three years substantially contributed to the associated increased risk. CONCLUSION: In evaluations of overall organ damage in SLE, GC exposure during at least the previous year should be considered to capture the associated increased risk. For cardiovascular damage, the time window for assessing GC exposure and disease activity should be extended to the last three years.
引用
- Dominicus A, Gomez Á, Nguyen NV, et al. Oral Glucocorticoid Dose Patterns and Organ Damage in Systemic Lupus Erythematosus-A Nationwide Cohort Study. Arthritis Rheumatol. 2026. PMID: 42827375. doi:10.1002/art.70360
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。